Literature DB >> 17516729

Verrucous psoriasis in a patient with chronic C hepatitis treated with interferon.

Sebastiano Scavo1, Alessandra Gurrera, Claudio Mazzaglia, Gaetano Magro, Davide Pulvirenti, Erika Gozzo, Sergio Neri.   

Abstract

Entities:  

Year:  2004        PMID： 17516729     DOI： 10.2165/00044011-200424070-00006

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  9 in total

Review 1.  EASL International Consensus Conference on Hepatitis C. Paris, 26-28, February 1999, Consensus Statement. European Association for the Study of the Liver.

Authors: 
Journal:  J Hepatol       Date:  1999-05       Impact factor: 25.083

Review 2.  [Cutaneous side effects of interferons].

Authors:  P Paquet; C Piérard-Franchimont; J E Arrese; G E Piérard
Journal:  Rev Med Liege       Date:  2001-10

3.  Oral psoriasis in a patient with hepatitis C virus infection.

Authors:  Toshiyuki Yamamoto; Kiyoshi Nishioka
Journal:  Eur J Dermatol       Date:  2002 Jan-Feb       Impact factor: 3.328

4.  Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis.

Authors:  Peck Y Ong; Qutayba A Hamid; Jeffrey B Travers; Ian Strickland; Muhamed Al Kerithy; Mark Boguniewicz; Donald Y M Leung
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

5.  Psoriatic arthritis with spinal involvement in a patient receiving alpha-interferon for chronic hepatitis C.

Authors:  F Lombardini; E Taglione; L Riente; G Pasero
Journal:  Scand J Rheumatol       Date:  1997       Impact factor: 3.641

Review 6.  Immune-mediated complications during interferon therapy in hematological patients.

Authors:  Pia Raanani; Isaac Ben-Bassat
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

Review 7.  Cutaneous reactions to recombinant cytokine therapy.

Authors:  L A Asnis; A A Gaspari
Journal:  J Am Acad Dermatol       Date:  1995-09       Impact factor: 11.527

8.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

9.  Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors.

Authors:  Amos Gilhar; Yehuda Ullmann; Hedviga Kerner; Bedia Assy; Raya Shalaginov; Sima Serafimovich; Richard S Kalish
Journal:  J Invest Dermatol       Date:  2002-08       Impact factor: 8.551
  9 in total
  4 in total

Review 1.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

Review 2.  Janus-like effects of type I interferon in autoimmune diseases.

Authors:  Robert C Axtell; Chander Raman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 3.  Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity.

Authors:  Robert C Axtell; Chander Raman; Lawrence Steinman
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 4.  Verrucous psoriasis in a male patient with a history of vulgar psoriasis: Case report and literature review

Authors:  Javier Hernández; Ana Ruiz; Carolina Mesa; Lina Rodríguez
Journal:  Biomedica       Date:  2021-09-22       Impact factor: 0.935
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.